(%)
Market is Open
Last quote from:
After-Hours Quote
Market is closed for
(%)
After-Hours Quote is Unavailable
Market is Open
Last quote from:
After-Hours Quote
Market is closed for
(%)
After-Hours Quote is Unavailable
- Ownership
-
ANI Pharmaceuticals, Inc. Insider Trading
* In original currency USD
Loading Data
Transaction Date (SEC Report) |
Reporting Name | Relationship | Shrs. Owned | Type | Acq./Disp. | Shrs. Transacted | Price | Total Amount |
---|---|---|---|---|---|---|---|---|
Friday, June 13th, 2025 | Cook Meredith | officer: SR. VP, GENERAL COUNSEL & SEC. | 79,345 | S-Sale | D | 400 | 61.37 USD | 24,548 USD |
Thursday, May 22nd, 2025 | HAUGHEY THOMAS | director | 55,862 | A-Award | A | 4,336 | 0.00 USD | 0 USD |
Thursday, May 22nd, 2025 | Leonard Matthew J | director | 16,329 | A-Award | A | 4,336 | 0.00 USD | 0 USD |
Thursday, May 22nd, 2025 | Pera Antonio R | director | 35,373 | A-Award | A | 4,336 | 0.00 USD | 0 USD |
Thursday, May 22nd, 2025 | TANNENBAUM RENEE P | director | 26,957 | A-Award | A | 4,336 | 0.00 USD | 0 USD |
Thursday, May 22nd, 2025 | Thoma Jeanne | director | 44,945 | A-Award | A | 4,336 | 0.00 USD | 0 USD |
Thursday, May 22nd, 2025 | Walsh Patrick D | director | 79,048 | A-Award | A | 4,336 | 0.00 USD | 0 USD |
Thursday, May 15th, 2025 | Gutwerg Ori | officer: SVP, GENERICS | 89,897 | S-Sale | D | 881 | 60.07 USD | 52,922 USD |
Wednesday, May 14th, 2025 | Mutz Christopher | officer: HEAD OF RARE DISEASE | 107,317 | S-Sale | D | 4,000 | 60.45 USD | 241,800 USD |
Tuesday, May 13th, 2025 | Cook Meredith | officer: SR. VP, GENERAL COUNSEL & SEC. | 79,745 | S-Sale | D | 400 | 62.20 USD | 24,880 USD |
Friday, May 9th, 2025 | Shanmugam Muthusamy | director, officer: HEAD OF R&D, COO-NOVITIUM OPS | 631,920 | S-Sale | D | 700 | 76.83 USD | 53,781 USD |
Monday, April 14th, 2025 | Cook Meredith | officer: SR. VP, GENERAL COUNSEL & SEC. | 80,145 | S-Sale | D | 400 | 68.96 USD | 27,584 USD |
Sunday, March 23rd, 2025 | Lalwani Nikhil | director, officer: PRESIDENT & CEO | 468,179 | F-InKind | D | 17,455 | 64.26 USD | 1,121,658 USD |
Sunday, March 23rd, 2025 | CAREY STEPHEN P. | officer: SVP & CFO | 180,863 | F-InKind | D | 6,210 | 64.26 USD | 399,055 USD |
Wednesday, March 19th, 2025 | Davis Krista | officer: SVP, CHIEF HR OFFICER | 64,659 | S-Sale | D | 1,866 | 65.00 USD | 121,290 USD |
Thursday, March 13th, 2025 | Cook Meredith | officer: SR. VP, GENERAL COUNSEL & SEC. | 80,545 | S-Sale | D | 400 | 63.33 USD | 25,332 USD |
Friday, March 7th, 2025 | Mutz Christopher | officer: HEAD OF RARE DISEASE | 111,317 | F-InKind | D | 2,874 | 60.62 USD | 174,222 USD |
Friday, March 7th, 2025 | Lalwani Nikhil | director, officer: PRESIDENT & CEO | 485,634 | F-InKind | D | 17,060 | 60.62 USD | 1,034,177 USD |
Friday, March 7th, 2025 | Gutwerg Ori | officer: SVP, GENERICS | 90,778 | F-InKind | D | 3,314 | 60.62 USD | 200,895 USD |
Friday, March 7th, 2025 | CAREY STEPHEN P. | officer: SVP & CFO | 187,073 | F-InKind | D | 5,150 | 60.62 USD | 312,193 USD |
Friday, March 7th, 2025 | Davis Krista | officer: SVP, CHIEF HR OFFICER | 66,525 | S-Sale | D | 1,000 | 60.86 USD | 60,860 USD |
Wednesday, March 5th, 2025 | Gutwerg Ori | officer: SVP, GENERICS | 99,476 | M-Exempt | A | 300 | 31.49 USD | 9,447 USD |
Wednesday, March 5th, 2025 | Gutwerg Ori | officer: SVP, GENERICS | 99,176 | S-Sale | D | 300 | 60.03 USD | 18,009 USD |
Wednesday, March 5th, 2025 | Gutwerg Ori | officer: SVP, GENERICS | 94,092 | S-Sale | D | 5,084 | 60.00 USD | 305,040 USD |
Wednesday, March 5th, 2025 | Gutwerg Ori | officer: SVP, GENERICS | 13,204 | M-Exempt | D | 300 | 31.49 USD | 9,447 USD |
Friday, February 28th, 2025 | Rowland Thomas Andrew | officer: SVP, HEAD - ESTABLISHED BRANDS | 45,465 | F-InKind | D | 627 | 61.89 USD | 38,805 USD |
Friday, February 28th, 2025 | Mutz Christopher | officer: HEAD OF RARE DISEASE | 114,191 | F-InKind | D | 1,275 | 61.89 USD | 78,910 USD |
Friday, February 28th, 2025 | Lalwani Nikhil | director, officer: PRESIDENT & CEO | 502,694 | F-InKind | D | 12,216 | 61.89 USD | 756,048 USD |
Friday, February 28th, 2025 | Gutwerg Ori | officer: SVP, GENERICS | 99,176 | F-InKind | D | 1,570 | 61.89 USD | 97,167 USD |
Friday, February 28th, 2025 | Davis Krista | officer: SVP, CHIEF HR OFFICER | 67,525 | F-InKind | D | 1,099 | 61.89 USD | 68,017 USD |
Friday, February 28th, 2025 | Cook Meredith | officer: SR. VP, GENERAL COUNSEL & SEC. | 80,945 | F-InKind | D | 1,099 | 61.89 USD | 68,017 USD |
Friday, February 28th, 2025 | CAREY STEPHEN P. | officer: SVP & CFO | 192,223 | F-InKind | D | 1,861 | 61.89 USD | 115,177 USD |
Friday, February 21st, 2025 | Davis Krista | officer: SVP, CHIEF HR OFFICER | 68,624 | S-Sale | D | 1,000 | 60.20 USD | 60,200 USD |
Wednesday, February 12th, 2025 | Shanmugam Muthusamy | director, officer: HEAD OF R&D, COO-NOVITIUM OPS | 92,588 | A-Award | A | 9,574 | 0.00 USD | 0 USD |
Wednesday, February 12th, 2025 | Shanmugam Muthusamy | director, officer: HEAD OF R&D, COO-NOVITIUM OPS | 83,014 | A-Award | A | 14,362 | 0.00 USD | 0 USD |
Wednesday, February 12th, 2025 | Rowland Thomas Andrew | officer: SVP, HEAD - ESTABLISHED BRANDS | 46,674 | A-Award | A | 5,222 | 0.00 USD | 0 USD |
Friday, February 14th, 2025 | Rowland Thomas Andrew | officer: SVP, HEAD - ESTABLISHED BRANDS | 46,092 | F-InKind | D | 582 | 58.92 USD | 34,291 USD |
Wednesday, February 12th, 2025 | Rowland Thomas Andrew | officer: SVP, HEAD - ESTABLISHED BRANDS | 41,452 | A-Award | A | 7,834 | 0.00 USD | 0 USD |
Wednesday, February 12th, 2025 | Mutz Christopher | officer: HEAD OF RARE DISEASE | 118,123 | A-Award | A | 16,538 | 0.00 USD | 0 USD |
Friday, February 14th, 2025 | Mutz Christopher | officer: HEAD OF RARE DISEASE | 116,650 | F-InKind | D | 1,473 | 58.92 USD | 86,789 USD |
Saturday, February 15th, 2025 | Mutz Christopher | officer: HEAD OF RARE DISEASE | 115,466 | F-InKind | D | 1,184 | 58.92 USD | 69,761 USD |
Wednesday, February 12th, 2025 | Mutz Christopher | officer: HEAD OF RARE DISEASE | 101,585 | A-Award | A | 24,808 | 0.00 USD | 0 USD |
Wednesday, February 12th, 2025 | Lalwani Nikhil | director, officer: PRESIDENT & CEO | 522,709 | A-Award | A | 60,932 | 0.00 USD | 0 USD |
Friday, February 14th, 2025 | Lalwani Nikhil | director, officer: PRESIDENT & CEO | 514,910 | F-InKind | D | 7,799 | 58.92 USD | 459,517 USD |
Wednesday, February 12th, 2025 | Lalwani Nikhil | director, officer: PRESIDENT & CEO | 461,777 | A-Award | A | 91,399 | 0.00 USD | 0 USD |
Wednesday, February 12th, 2025 | Gutwerg Ori | officer: SVP, GENERICS | 103,339 | A-Award | A | 10,444 | 0.00 USD | 0 USD |
Friday, February 14th, 2025 | Gutwerg Ori | officer: SVP, GENERICS | 101,913 | F-InKind | D | 1,426 | 58.92 USD | 84,020 USD |
Saturday, February 15th, 2025 | Gutwerg Ori | officer: SVP, GENERICS | 100,746 | F-InKind | D | 1,167 | 58.92 USD | 68,760 USD |
Wednesday, February 12th, 2025 | Gutwerg Ori | officer: SVP, GENERICS | 92,895 | A-Award | A | 15,668 | 0.00 USD | 0 USD |
Wednesday, February 12th, 2025 | Gassert Chad | officer: SVP - CORP. DEV. & STRATEGY | 73,615 | A-Award | A | 9,574 | 0.00 USD | 0 USD |
Wednesday, February 12th, 2025 | Gassert Chad | officer: SVP - CORP. DEV. & STRATEGY | 64,041 | A-Award | A | 14,362 | 0.00 USD | 0 USD |
Wednesday, February 12th, 2025 | Davis Krista | officer: SVP, CHIEF HR OFFICER | 70,820 | A-Award | A | 8,704 | 0.00 USD | 0 USD |
Friday, February 14th, 2025 | Davis Krista | officer: SVP, CHIEF HR OFFICER | 69,624 | F-InKind | D | 1,196 | 58.92 USD | 70,468 USD |
Wednesday, February 12th, 2025 | Davis Krista | officer: SVP, CHIEF HR OFFICER | 62,116 | A-Award | A | 13,057 | 0.00 USD | 0 USD |
Wednesday, February 12th, 2025 | Cook Meredith | officer: SR. VP, GENERAL COUNSEL & SEC. | 83,878 | A-Award | A | 11,316 | 0.00 USD | 0 USD |
Thursday, February 13th, 2025 | Cook Meredith | officer: SR. VP, GENERAL COUNSEL & SEC. | 83,478 | S-Sale | D | 400 | 59.54 USD | 23,816 USD |
Friday, February 14th, 2025 | Cook Meredith | officer: SR. VP, GENERAL COUNSEL & SEC. | 82,044 | F-InKind | D | 1,434 | 58.92 USD | 84,491 USD |
Wednesday, February 12th, 2025 | Cook Meredith | officer: SR. VP, GENERAL COUNSEL & SEC. | 72,562 | A-Award | A | 16,974 | 0.00 USD | 0 USD |
Wednesday, February 12th, 2025 | CAREY STEPHEN P. | officer: SVP & CFO | 195,814 | A-Award | A | 16,538 | 0.00 USD | 0 USD |
Friday, February 14th, 2025 | CAREY STEPHEN P. | officer: SVP & CFO | 194,084 | F-InKind | D | 1,730 | 58.92 USD | 101,932 USD |
Wednesday, February 12th, 2025 | CAREY STEPHEN P. | officer: SVP & CFO | 179,276 | A-Award | A | 24,808 | 0.00 USD | 0 USD |
Monday, January 13th, 2025 | Cook Meredith | officer: SR. VP, GENERAL COUNSEL & SEC. | 55,588 | S-Sale | D | 400 | 53.92 USD | 21,568 USD |
Tuesday, December 17th, 2024 | CAREY STEPHEN P. | officer: SVP & CFO | 154,468 | S-Sale | D | 7,500 | 55.79 USD | 418,425 USD |
Friday, December 13th, 2024 | Cook Meredith | officer: SR. VP, GENERAL COUNSEL & SEC. | 55,988 | S-Sale | D | 250 | 56.24 USD | 14,060 USD |
Wednesday, December 11th, 2024 | Davis Krista | officer: SVP, CHIEF HR OFFICER | 49,059 | S-Sale | D | 1,000 | 60.00 USD | 60,000 USD |
Tuesday, November 26th, 2024 | Lalwani Nikhil | director, officer: PRESIDENT & CEO | 403,859 | M-Exempt | A | 30,000 | 29.00 USD | 870,000 USD |
Tuesday, November 26th, 2024 | Lalwani Nikhil | director, officer: PRESIDENT & CEO | 373,859 | S-Sale | D | 30,000 | 57.95 USD | 1,738,500 USD |
Tuesday, November 26th, 2024 | Lalwani Nikhil | director, officer: PRESIDENT & CEO | 370,378 | S-Sale | D | 3,481 | 58.30 USD | 202,942 USD |
Tuesday, November 26th, 2024 | Lalwani Nikhil | director, officer: PRESIDENT & CEO | 138,027 | M-Exempt | D | 30,000 | 29.00 USD | 870,000 USD |
Friday, November 15th, 2024 | Rowland Thomas Andrew | officer: SVP, HEAD - ESTABLISHED BRANDS | 33,169 | F-InKind | D | 867 | 56.58 USD | 49,055 USD |
Friday, November 15th, 2024 | Mutz Christopher | officer: HEAD OF RARE DISEASE | 76,777 | S-Sale | D | 6,500 | 57.70 USD | 375,050 USD |
Wednesday, November 13th, 2024 | Cook Meredith | officer: SR. VP, GENERAL COUNSEL & SEC. | 56,238 | S-Sale | D | 250 | 61.36 USD | 15,340 USD |
Monday, October 14th, 2024 | Cook Meredith | officer: SR. VP, GENERAL COUNSEL & SEC. | 56,488 | S-Sale | D | 250 | 57.19 USD | 14,298 USD |
Friday, September 13th, 2024 | Cook Meredith | officer: SR. VP, GENERAL COUNSEL & SEC. | 56,738 | S-Sale | D | 250 | 56.82 USD | 14,205 USD |
Thursday, September 12th, 2024 | Davis Krista | officer: SVP, CHIEF HR OFFICER | 50,059 | F-InKind | D | 1,486 | 56.15 USD | 83,439 USD |
Sunday, September 8th, 2024 | Lalwani Nikhil | director, officer: PRESIDENT & CEO | 373,859 | F-InKind | D | 3,646 | 60.51 USD | 220,620 USD |
Tuesday, August 13th, 2024 | Cook Meredith | officer: SR. VP, GENERAL COUNSEL & SEC. | 56,988 | S-Sale | D | 250 | 59.62 USD | 14,905 USD |
Thursday, July 18th, 2024 | Shanmugam Muthusamy | director, officer: HEAD OF R&D, COO-NOVITIUM OPS | 632,620 | S-Sale | D | 2,743 | 62.00 USD | 170,066 USD |
Thursday, July 18th, 2024 | Cook Meredith | officer: SR. VP, GENERAL COUNSEL & SEC. | 57,238 | F-InKind | D | 1,743 | 61.35 USD | 106,933 USD |
Monday, July 15th, 2024 | Shanmugam Muthusamy | director, officer: HEAD OF R&D, COO-NOVITIUM OPS | 671,620 | S-Sale | D | 11,000 | 63.38 USD | 697,180 USD |
Tuesday, July 16th, 2024 | Shanmugam Muthusamy | director, officer: HEAD OF R&D, COO-NOVITIUM OPS | 649,620 | S-Sale | D | 22,000 | 64.27 USD | 1,413,940 USD |
Wednesday, July 17th, 2024 | Shanmugam Muthusamy | director, officer: HEAD OF R&D, COO-NOVITIUM OPS | 635,363 | S-Sale | D | 14,257 | 63.16 USD | 900,472 USD |
Friday, July 12th, 2024 | Cook Meredith | officer: SR. VP, GENERAL COUNSEL & SEC. | 58,981 | S-Sale | D | 250 | 64.91 USD | 16,228 USD |
Monday, July 1st, 2024 | Gassert Chad | officer: SVP - CORP. DEV. & STRATEGY | 193,226 | S-Sale | D | 20,000 | 63.44 USD | 1,268,800 USD |
Friday, June 21st, 2024 | Shanmugam Muthusamy | director, officer: HEAD OF R&D, COO-NOVITIUM OPS | 682,620 | S-Sale | D | 20,000 | 58.90 USD | 1,178,000 USD |
Monday, June 17th, 2024 | Shanmugam Muthusamy | director, officer: HEAD OF R&D, COO-NOVITIUM OPS | 724,674 | S-Sale | D | 7,946 | 61.41 USD | 487,964 USD |
Tuesday, June 18th, 2024 | Shanmugam Muthusamy | director, officer: HEAD OF R&D, COO-NOVITIUM OPS | 714,067 | S-Sale | D | 10,607 | 60.76 USD | 644,481 USD |
Thursday, June 20th, 2024 | Shanmugam Muthusamy | director, officer: HEAD OF R&D, COO-NOVITIUM OPS | 702,620 | S-Sale | D | 11,447 | 59.86 USD | 685,217 USD |
Thursday, June 13th, 2024 | Cook Meredith | officer: SR. VP, GENERAL COUNSEL & SEC. | 59,231 | S-Sale | D | 250 | 63.80 USD | 15,950 USD |
Friday, June 7th, 2024 | Marken James G. | officer: SVP OPS & PROD DEV | 128,916 | M-Exempt | A | 5,300 | 57.06 USD | 302,418 USD |
Friday, June 7th, 2024 | Marken James G. | officer: SVP OPS & PROD DEV | 123,616 | M-Exempt | A | 7,250 | 49.51 USD | 358,948 USD |
Friday, June 7th, 2024 | Marken James G. | officer: SVP OPS & PROD DEV | 117,829 | F-InKind | D | 11,087 | 67.70 USD | 750,590 USD |
Friday, June 7th, 2024 | Marken James G. | officer: SVP OPS & PROD DEV | 0 | M-Exempt | D | 7,250 | 49.51 USD | 358,948 USD |
Friday, June 7th, 2024 | Marken James G. | officer: SVP OPS & PROD DEV | 0 | M-Exempt | D | 5,300 | 57.06 USD | 302,418 USD |
Wednesday, June 5th, 2024 | Gutwerg Ori | officer: SVP, GENERICS | 77,227 | S-Sale | D | 2,985 | 67.00 USD | 199,995 USD |
Tuesday, June 4th, 2024 | CAREY STEPHEN P. | officer: SVP & CFO | 161,968 | S-Sale | D | 5,000 | 63.58 USD | 317,900 USD |
Monday, June 3rd, 2024 | Gassert Chad | officer: SVP - CORP. DEV. & STRATEGY | 213,226 | S-Sale | D | 20,000 | 64.41 USD | 1,288,200 USD |
Tuesday, May 21st, 2024 | Walsh Patrick D | director | 74,712 | A-Award | A | 4,410 | 0.00 USD | 0 USD |
Tuesday, May 21st, 2024 | Thoma Jeanne | director | 40,609 | A-Award | A | 4,410 | 0.00 USD | 0 USD |
Tuesday, May 21st, 2024 | TANNENBAUM RENEE P | director | 22,621 | A-Award | A | 4,410 | 0.00 USD | 0 USD |